# Genetic Variability in CYP2D6 in U.S Active Duty Population

> **NCT02960568** · PHASE1 · COMPLETED · sponsor: **Walter Reed Army Institute of Research (WRAIR)** · enrollment: 550 (actual)

## Conditions studied

- Pharmacologic Action

## Interventions

- **DRUG:** Primaquine

## Key facts

- **NCT ID:** NCT02960568
- **Lead sponsor:** Walter Reed Army Institute of Research (WRAIR)
- **Sponsor class:** FED
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-08
- **Primary completion:** 2017-07
- **Final completion:** 2017-08
- **Target enrollment:** 550 (ACTUAL)
- **Last updated:** 2021-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02960568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02960568, "Genetic Variability in CYP2D6 in U.S Active Duty Population". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02960568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*